Category: NASDAQ:SHPG

Can The Record Breaking Number Of FDA New Drug Approvals Continue?

Despite these possibilities, the boom in new drugs is likely to continue benefiting the industry and more importantly, the patients anxiously waiting for these new treatments.

Takeda Acquisition Of Shire May Bode Well For R&D Staff

“We think that the fit is very strong between Takeda and Shire. We foresee minimal disruption on the R&D front.”

Sticker Shock: The Real Cost Of America’s 10 Most Expensive Drugs

The high price of pharmaceuticals have become a constant topic of discussion in the U.S. although very few consumers ever pay out-of-pocket prices thanks to insurance. But in the case that an individual had to pay list price, the following 10 drugs are…